Klaria Pharma Holding AB
6FN
Company Profile
Business description
Klaria Pharma Holding AB is a Swedish pharmaceutical company that develops rapid-acting products. By combining patented technology of a film that attaches to the oral mucosa and pharmaceuticals, the company has developed a drug distribution concept with many benefits and potential uses. Its patented drug delivery platform consists of an alginate-based polymer film that enables the absorption of a product's active substance through the oral mucosa.
Contact
Virdings Alle 2
Uppsala754 50
CHET: +41 84464299
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 December 2026
Employees
4
Stocks News & Analysis
stocks
An undervalued stock to buy that even Warren Buffett likes
Trading at an 18% discount, this wide-moat stock is a rare find.
stocks
Ahead of an IPO, the maths behind Databrick’s $190 billion valuation doesn’t add up
The data and AI company is one of the world’s strongest private companies, but a PitchBook report says it’s unattractive at the current price.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,850.70 | 5.10 | 0.06% |
| CAC 40 | 8,131.06 | 53.26 | 0.66% |
| DAX 40 | 25,509.05 | 100.41 | 0.40% |
| Dow JONES (US) | 51,569.93 | 258.69 | -0.50% |
| FTSE 100 | 10,745.76 | 50.51 | 0.47% |
| HKSE | 24,642.51 | 132.42 | 0.54% |
| NASDAQ | 26,921.80 | 146.91 | -0.54% |
| Nikkei 225 | 65,877.62 | 486.59 | -0.73% |
| NZX 50 Index | 13,830.68 | 19.57 | 0.14% |
| S&P 500 | 7,710.36 | 33.05 | -0.43% |
| S&P/ASX 200 | 8,679.70 | 14.70 | 0.17% |
| SSE Composite Index | 3,823.62 | 64.75 | -1.67% |